Table 2 Dose escalations

From: A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma

Carboplatin dose

No. assessable patients

No. courses

No. with DLT

Stage 1: Temozolomide dose 750 mg m 2

 AUC 3

3

10

0

 AUC 4

3

11

0

 AUC 5

3

7

0

 AUC 6

3

5

0

Stage 2: Temozolomide dose 1000mgm−2

 AUC 3

3

13

0

 AUC 4

11

35

8

 AUC 5

4

8

2

DLT=dose limiting toxicity.AUC=Area under curve.